BICO Group AB (publ) (STO: BICO)

Market Cap	2.28B
Revenue (ttm)	2.33B
Net Income (ttm)	-1.72B
Shares Out	70.57M
EPS (ttm)	-24.43
PE Ratio	n/a
Forward PE	18.27
Dividend	n/a
Ex-Dividend Date	n/a

Volume	95,593
Open	32.98
Previous Close	32.50
Day's Range	31.50 - 32.98
52-Week Range	29.32 - 62.62
Beta	2.36
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 26, 2024

About BICO Group AB

BICO Group AB (publ) operates as a bioconvergence company in North America, Europe, Asia, and internationally. It operates through three segments: Bioprinting, Biosciences, and Bioautomation. The Bioprinting segment offers products, solutions, and services that enable proliferation of 3D cell culture and 3D printing. The Biosciences segment provides instruments that enable the handling of cells and rare samples, and rapid transfer of liquids and reagents, as well as downstream analysis platforms. The Bioautomation segment offers end-to-end prod...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2016
• Employees: 880
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BICO

Financial Performance

In 2023, BICO Group AB's revenue was 2.40 billion, an increase of 3.35% compared to the previous year's 2.33 billion. Losses were -1.98 billion, 138.1% more than in 2022.